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Urinary Exosomes Contain 
MicroRNAs Capable of Paracrine 
Modulation of Tubular Transporters 
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Pablo Moreno1, Gos Micklem4 & Fiona E. Karet Frankl1
Exosomes derived from all nephron segments are present in human urine, where their functionality 
is incompletely understood. Most studies have focused on biomarker discovery rather than exosome 
function. Through sequencing we identified the miRNA repertoire of urinary exosomes from healthy 
volunteers; 276 mature miRNAs and 345 pre-miRNAs were identified (43%/7% of reads). Among the 
most abundant were members of the miR-10, miR-30 and let-7 families. Targets for the identified 
miRNAs were predicted using five different databases; genes encoding membrane transporters and 
their regulators were enriched, highlighting the possibility that these miRNAs could modulate key 
renal tubular functions in a paracrine manner. As proof of concept, cultured renal epithelial cells were 
exposed to urinary exosomes and cellular exosomal uptake was confirmed; thereafter, reduced levels 
of the potassium channel ROMK and kinases SGK1 and WNK1 were observed in a human collecting duct 
cell line, while SPAK was unaltered. In proximal tubular cells, mRNA levels of the amino acid transporter 
gene SLC38A2 were diminished and reflected in a significant decrement of its encoded protein SNAT2. 
Protein levels of the kinase SGK1 did not change. Thus we demonstrated a novel potential function for 
miRNA in urinary exosomes.
Urinary exosomes are lipid membrane-bound nanovesicles released from intracellular multivesicular bodies 
(MVBs)1,2 and derived from all cells in the urinary tract3–5. During the inward budding of endosomes that give ori-
gin to exosomes, proteins2, mRNAs6, microRNAs (miRNAs)7, noncoding RNA (ncRNA)8, transcription factors9  
and other biomolecules present in the cytosol can be incorporated. The lipid bi-layer of these nanovesicles pro-
vides the cargo with stable storage conditions and protects it from degradation by extracellular proteases and 
ribonucleases10. Studies in other tissues have shown that once exosomes and other microvesicles are released into 
the extracellular environment, interactions with cells can occur by direct ligand-receptor signalling, by exosomal 
fusion to the target cell membrane and discharge of exosomal content directly into the cytoplasm, or via phago-
cytosis/macropinocytosis11,12. Exosomes are known to deliver biologic cargo not only to neighbouring cells but 
also long distance13.
The majority of studies concerning urinary exosomes have focused on their potential as biomarkers of disease 
pathology and progression, including prostate and bladder cancers14–17, but their functional significance is now 
being addressed. Inter-cellular signalling by exosomes in cultured murine renal epithelial cells was demonstrated 
for the first time by Street et al.18, who suggested that collecting duct cell-derived exosomes can transfer the ability 
to express AQP2. Our previous studies revealed that urinary exosomes inhibit bacterial growth of both com-
mensal and uropathogenic E. coli by inducing bacterial lysis19. Bruschi and colleagues demonstrated that urinary 
exosomes can consume oxygen in order to synthesize ATP aerobically, thus suggesting metabolic activity20, and 
Jiang et al. showed that urinary exosomes derived from stem cells may have the potential to inhibit podocyte 
apoptosis and promote vascular regeneration in the kidney21.
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Various protein compendia of urinary exosomes have been reported3,5,19,22–26, but the identification of their 
miRNA content has been limited to one sequence based study10, and three studies utilising RT-qPCR or microar-
ray approaches that restrict the study to a specific set of known miRNAs7,15,27. The lack of efficient methods to iso-
late small RNAs from vesicles has been a constraint to miRNA profiling, and there is no consensus regarding the 
optimal method for isolation of exosomes. Here we aimed to identify the miRNA repertoire of urinary exosomes 
from healthy individuals using the most efficient methods available for exosomal isolation and small RNA extrac-
tion. We also investigated the direct effects of exosomal miRNA on gene expression and protein levels of selected 
predicted targets in kidney-derived cell lines.
Results
Urinary exosome isolation and miRNA extraction. Exosomes from the second morning urine void 
of healthy volunteers on no regular medication and with no urinary dipstick abnormalities (aged 32–46 y) were 
isolated as previously described19. Electron microscopy images showed the expected intact vesicles of diameter 
59.0 ± 1.93 nm; 92% of the population fell in the 30–80 nm range (Supplementary Figure S1). Western blots con-
firmed the presence of the exosomal markers CD63 and TSG101 in these isolated vesicles but not in exosome-de-
pleted urine (Supplementary Figure S1). The uromodulin content of these preparations was 10–30% of the total 
protein.
We successfully purified and quantified exosomal small RNAs. Electropherograms showed characteristic 
peaks of both miRNA and other non-coding RNA (ncRNA) species (Fig. 1A). The profiles varied somewhat 
among subjects, particularly over the size range 40–100 nucleotides (which includes pre-miRNAs, tRNAs, rRNAs 
and snoRNAs). Amounts of miRNA packaged in the exosomes were 7.3 ± 1.7 ng per 100 ml of urine, and the 
proportion of miRNA compared to other small RNAs was 50.4 ± 5.7% (Supplementary Table S1). There were no 
significant differences between male and female subgroups (p = 0.29).
Next Generation Sequencing. After adapter trimming and quality filtering, just over 107 reads were 
obtained and aligned to miRBase V19. 0.49% corresponded to sequences in the E. coli genome (E. coli K-12 
Figure 1. Characterization of the small RNA content of urinary exosomes. (A) Bioanalyzer profiles of small 
RNAs isolated from urinary exosomes of two different volunteers analysed on Small RNA chip. Both profiles 
exhibited enrichment for the miRNA region (arrowed). (B) Deep sequencing analysis of the small RNA fraction 
isolated from pooled urinary exosomes. Mature microRNAs and pre-microRNAs together comprised 50% of 
total reads.
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MG1655) and were discarded. 43% corresponded to known miRNA sequences, identifying 1197 miRNAs 
(Fig. 1B). A further 7% corresponded to pre-miRNAs. Those with fewer than 5 reads/million were discarded; 
276 mature miRNAs and 345 pre-miRNAs were retained for further analysis (Supplementary Tables S2 and S3). 
Table 1 shows the 10 most abundant miRNAs and pre-miRNAs. Five of these were also reported in the top 10 
most abundant miRNAs and pre-miRNAs in the only other sequence-based analysis of this type of exosome10.
After miRNAs and their precursors, other RNA types accounted for a very small fraction of all mappable 
sequences; 0.28% were tRNAs, while snoRNA/snRNA, lincRNA and rRNA were only represented by 0.01% 
each. Misc_RNA (defined as any ncRNA that cannot be categorised as anything else) covered 0.17% of the total. 
Fragments of coding RNA sequences represented a further 0.18%. Almost half of the total reads were classified 
as unmapped (no match to sequences of E. coli, human coding RNA, miRNAs, pre-miRNAs, or other ncRNAs), 
likely due to the strict sequence alignment parameters employed.
RT-qPCR validation of urinary exosome miRNAs. Five miRNAs with different read counts ranging 
from 50 to 5.6 × 105 counts per million (CPM) were selected for RT-qPCR validation assays: miR10a, miR10b and 
miR30a (abundant), and miR-148a-3p and miR-152 (low abundance). Melting curve analyses showed specific 
amplification with no primer dimer or non-specific products. As shown in Fig. 2, expression levels of miR-10b-5p 
and miR10a-5p were 9 and 2.5 fold higher than miR30a-5p respectively, and all five were in agreement with the 
relative abundance ratios suggested by the sequencing data.
miRNA target prediction. We next investigated potential roles of the ten most abundant exosomal miRNAs 
by inferring their target relationships. Interrogation of five databases for target prediction (MiRBase28, miRanda29, 
PicTar30, PITA31 and miRDB32), with acceptance of results present in three or more databases, yielded a target 
list of genes that were ranked by average of the co-expression scores generated from each of the three databases.
1588 potential targets were identified; 66 of these are known kidney transporters in both proximal and distal 
nephron. Examples include several members of the solute carrier family (SLC), which transport amino acids, glu-
cose and charged and uncharged molecules. Among the most frequently targeted were SLC38A2, which encodes 
the amino acid transporter SNAT2, and the Ca2+ transporting ATPase gene ATP2B1, targeted by six and four 
of the ten most abundant miRNAs, respectively. Genes involved in regulation of essential renal physiological 
Rank miRNA CPM Rank pre-miRNA CPM
1 hsa-miR-10b-5p 558287 1 hsa-mir-30a 418851
2 hsa-miR-10a-5p 191562 2 hsa-mir-10b 171532
3 hsa-miR-30a-5p 50322 3 hsa-mir-30d 132932
4 hsa-miR-26a-5p 28774 4 hsa-mir-10a 95206
5 hsa-miR-22-3p 21503 5 hsa-mir-192 30327
6 hsa-miR-204-5p 18471 6 hsa-mir-204 26862
7 hsa-miR-181a-5p 17499 7 hsa-mir-30e 23683
8 hsa-miR-27b-3p 14522 8 hsa-mir-151a 14407
9 hsa-miR-30d-5p 13272 9 hsa-mir-222 7655
10 hsa-miR-192-5p 7684 10 hsa-mir-200b 7278
Table 1.  Most abundant urinary exosomal mature miRNAs and pre-miRNAs. CPM, counts per million; 
species in bold are common to both lists.
Figure 2. Validation of urinary exosomal miRNAs by RT-qPCR. The expression of selected miRNAs 
identified by deep sequencing with abundances ranging from 50 to 5.6 × 105 CPM was analysed using sno-
RNU6B for normalization. Comparative expression values are in agreement with the relative abundance ratios 
suggested by the sequencing data. Bars represent normalized expression mean ± SE of at least three independent 
replicates.
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processes such as kinases WNK1, SPAK and SGK1 were also frequently represented potential targets. WNK1 and 
SPAK were targets of at least 3 of the most abundant miRNAs (Supplementary Table 4).
Significant gene enrichment analysis of the target list using DAVID33 suggested potential regulatory roles 
of miRNAs found in urinary exosomes. Gene ontology terms highlighted the possibility for these miRNAs 
to exert effects on protein kinases and other regulators of key functions such as ion transport in the nephron 
(Table 2). This was supported by Kyoto Encyclopedia of Genes and Genomes (KEGG)34 pathway enrichment 
analysis, where predicted targets for the most abundant miRNAs were significantly associated with tubular trans-
port, endocytosis, ubiquitin mediated proteolysis and focal adhesion (Table 3). Interestingly, given our previous 
demonstration of the antibacterial effects of exosomes19, the pathway involving bacterial invasion of epithelial 
cells was among those listed.
Urinary exosome uptake by cultured human renal epithelial cells. To test the hypothesis that uri-
nary exosomal miRNA can affect protein expression, we first confirmed cellular uptake of these nanovesicles by 
cultured renal epithelial cells using live-cell microscopy. Fresh pooled urinary exosomes were surface-labelled 
with PKH67 and added to human collecting duct cells at 70–80% confluence. Exosomes were demonstrated to 
become adherent and internalized progressively over a 2 h period of observation; dye alone did not behave in this 
way (Fig. 3; Supplementary Videos S1 and S2). Cells looked normal after 2 h of live microscopy and were returned 
to standard culture conditions for another 48 h. At this point the cells had continued to divide to 100% plate con-
fluence, suggesting that exposure to labelled exosomes did not interfere with normal growth.
Target validation. For proof-of-concept that exosomal miRNA could possibly exert functional effects on 
cells, we chose to investigate membrane transporters that were in the top 10 predicted target genes, based on 
KEGG and DAVID analysis. We assessed the effect of exosomal miRNA on the expression of these selected genes 
in available kidney cell systems by PCR and western blot (Supplementary Figure 2). The selected genes were: 
KCNJ1 (encoding potassium channel ROMK1) and ATP2B1 (encoding plasma membrane calcium-transporting 
ATPase PMCA1) both expressed in the distal nephron and collecting duct cell line HCD; and SLC38A2 (encoding 
amino acid transporter SNAT2), expressed in the proximal tubule and in proximal cell line HKC-8. We confirmed 
Term P value Fold Enrichment Adjusted P value*
Serine/threonine protein kinase 7.8E-10 2.1 1.3E-06
Zinc finger, nuclear hormone receptor 2.5E-06 3.9 4.2E-03
ErbB signalling pathway 8.8E-06 2.8 1.1E-02
PDGF signalling pathway 1.3E-05 2.0 1.4E-02
EGFR signalling pathway 2.2E-05 3.7 2.2E-02
Rho GTPase signalling pathway 2.9E-05 2.5 2.9E-02
T cell receptor signalling pathway 3.6E-05 2.5 4.4E-02
Table 2.  DAVID enrichment analysis of predicted targets of the 10 most abundant miRNAs. *Benjamini-
Hochberg corrected False Discovery Rate.
Rank miRNA KEGG Pathway (all p ≤ 0.04)
1 hsa-miR-10b-5p Transcriptional misregulation in cancer
2 hsa-miR-10a-5p Transcriptional misregulation in cancer
3 hsa-miR-30a-5p
cGMP/PKG signalling
Aldosterone-regulated sodium reabsorption
Ubiquitin mediated proteolysis
4 Has-miR-26a-5p Proximal tubule bicarbonate reclamationFocal adhesion
5 hsa-miR-22-3p
Endocytosis
Bacterial invasion of epithelial cells
Fc gamma R-mediated phagocytosis
6 hsa-miR-204-5p LysosomeEndocrine and factor-regulated calcium reabsorption
7 hsa-miR-181a-5p
Estrogen signalling
Renal cell carcinoma
Prostate cancer
8 hsa-miR-27b-3p GnRH signallingTNF signalling
9 hsa-miR-30d-5p Mucin type O-Glycan biosynthesisUbiquitin mediated proteolysis
10 hsa-miR-192-5p RNA degradation,Type I diabetes mellitus
Table 3.  KEGG Pathway analysis for predicted targets of the 10 most abundant miRNAs.
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that there were no significant changes using either buffer alone or the prevalent urinary protein, uromodulin, in 
exposures for both cell lines (Supplementary Figure 3).
HCD cells incubated with 10 μ g of fresh urinary exosomes for 6, 24 or 48 h showed no changes in cell mor-
phology or confluence. Western blots of cell lysates revealed that protein expression levels of ROMK1 were 
decreased by nearly half after 48 h of exposure to exosomes (p < 0.0001 vs no exosomes, Fig. 4A). To examine the 
possible contributory effect of relevant kinases we quantified levels of SPAK35, SGK136 and WNK137 (Fig. 4B–D). 
Figure 3. Internalization of urinary exosomes by human collecting duct cells (HCD). Fresh PKH67-labelled 
urinary exosomes, or PKH67 dye only, were added to HCD cells and observed using cell live microscopy for 
approximately 2 h. Panels show representative images before (0 minutes) and at various times after exosome or 
dye addition. Accumulation of labelled exosomes inside cells is clearly observed after 56 minutes. Dye alone did 
not accumulate in cells. Bars indicate 10 μ m.
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SPAK levels did not change (Fig. 4B), excluding a non-specific effect of exosomes on these cells, while SGK1 
and WNK1 were reduced (Fig. 4C and D). Since these have opposing effects on ROMK1, the observed fall in 
ROMK1 levels is consistent with a direct effect of exosomal miRNA on KCNJ1. In support of this hypothesis, gene 
expression of KCNJ1, assessed by qRT-PCR normalized to GAPDH, was approximately 20% reduced at 24 h, with 
recovery by 48 h (Fig. 4F).
In the HCD cells, PMCA1 protein levels also decreased following exosomal exposure by approximately 50% 
(p = 0.002, Fig. 4E). This finding is consistent with a recent report that identified the miR-27 family, present in 
abundance in our exosomal samples, as down-regulators of ATP2B138.
In human proximal tubular cells (HKC-8), SNAT2 levels decreased significantly (p = 0.001), without any 
change in SGK1 (Fig. 5A and B). Expression levels of SLC38A2 analysed using qRT-PCR and the B2M gene (as the 
appropriate normalizer based on primer efficiency) revealed that gene expression was downregulated by approx-
imately 1/3 after 24 h, and this decrease was maintained after 48 h of incubation with urinary exosomes (Fig. 5C).
Figure 4. Effects of urinary exosomes on exemplar membrane transporters and regulators in human 
collecting duct cells (HCD). Panels A–E show western blots and densitometry analyses of HCD cell lysates 
following exposure of cells to 10 μ g of urinary exosomes for 6, 24 or 48 h. (A) ROMK1 levels significantly 
decreased after 48 h exposure; (B) SPAK did not change; (C) SGK1 and (D) WNK1 levels decreased at 48 h. 
(E) PMCA1 was also downregulated. Western blots are representative of three independent repeats for each 
analysed protein. Graphs show mean ± SE of densitometric intensity. (F) KCNJ1 expression levels in HCD were 
evaluated by RT-qPCR at the same timepoints. Expression levels decreased by 20% at 24 h but had increased 
at 48 h of exosomal exposure. Graph represents fold changes compared to control (no exosomes) of three 
independent repeats.
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Discussion
Urinary exosomes are being studied intensively to identify biomarkers for renal disease14,39–42, alongside an 
increasing focus on their biological effects18–21. Their functional significance is still incompletely understood and 
their full potential remains undeveloped. Our initial intention, to produce a catalogue of exosomal miRNAs, gave 
rise to the opportunity to provide proof of principle that these nanovesicles could be functional. Here, we provide 
the resulting catalogue, along with preliminary evidence that the miRNAs in urinary exosomes are biologically 
active and can directly engage in the modulation of protein levels of targeted genes.
The miRNA content of urinary exosomes has been variously reported7,10,15,27. We used the most efficient meth-
ods for urinary exosome isolation (ultracentrifugation), miRNA extraction (Qiagen miRNeasy-RNeasy)10,43 and 
small RNA library construction (Illumina TruSeq small RNA) that were available at the time. Unfortunately, there 
is no consensus of standard protocols to isolate urinary exosomes and although often only small technical mod-
ifications are made, the impact on the final results can be considerable. For example, it is controversial whether 
or not urine filtration prior to the preparation of urinary exosomes is necessary44. Alvarez and co-workers were 
the first to compare yields of protein, miRNA and mRNA using different methods of urinary exosome isolation43. 
Then, Cheng et al. reported exosomal and non-exosomal miRNA populations in urine comparing different 
miRNA purification methods and using Ion Torrent PGM for sequencing10. Although we recovered less miRNA 
per urine volume than reported by Cheng, the miRNA species identified were similar, with both datasets includ-
ing miR-10b-5p, miR10a-5p, miR30a-5p, miR26a-5p and miR-30d-5p among the top 10 most abundant miRNAs. 
Differences in amounts and abundance may be partly explained by Cheng’s use of frozen urine samples and omis-
sion of a filtration step; the first might reduce overall exosomal yield because of vesicular lysis, while the second 
increases the possibility of miRNA coming from cellular material. We demonstrated in preliminary experiments 
that the apparent quantity of miRNA obtained from urine which was not filtered was much higher when com-
pared with filtered urine from the same source (Supplementary Table S5), suggesting the erroneous inclusion of 
miRNA from non-exosomal sources in the unfiltered samples. Our exosomes were isolated from fresh samples 
filtered with a 0.22 μ m membrane before the ultracentrifugation step, thus the miRNA we purified will have 
originated from exosomes and not other cellular sources. Thus we advise filtration to ensure removal of cellular 
material before ultracentrifugation, which would likely introduce artefacts.
Various algorithms are available to predict miRNA targets28–32; they vary in their methodologies and levels of 
stringency for seed pairing and scoring, producing highly distinct results. The relevance of identifying miRNA 
families is that they point to common sequences or configuration in groups of genes, that suggest a common 
function45. Here we have included five different approaches, and to garner the highest sensitivity/specificity in 
Figure 5. Effects of urinary exosomes on SNAT2 and SGK1 in human proximal tubular cells (HKC-8). 
Panels A and B show western blots and densitometry analyses of HKC-8 cell lysates following exposure of cells 
to exosomes for 6, 24 or 48 h. Western blots are representative of three independent repeats for each analysed 
protein. (A) SNAT2 protein levels decreased after 48 h of exposure, whereas (B) SGK1 levels did not change. 
Graphs represent mean ± SE of densitometric intensity. (C) The expression of SLC38A2 in human proximal 
tubular cells (HKC-8) was evaluated by RT-qPCR at the same timepoints. Downregulation of SLC38A2 was 
observed at 24 h of exposure and maintained at 48 h. Graph represents fold changes compared to control (no 
exosomes) of three independent repeats.
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target selection, we listed targets only if they were predicted by at least 3 of these, which increases the likelihood of 
predicting true interactions. An important observation from our study is that targets predicted for the members 
of the miR-10, miR-30 and the let-7 miRNA families, listed among the most abundant, showed enrichment not 
only for genes encoding transporters of ions and organic molecules in the kidney but also of known regulators, 
suggesting potential correlations of miRNA families targeting or regulating specific renal functions.
For proof of concept that exosomal miRNAs might have functional effects on their predicted targets, we chose 
targets represented in the dataset that are expressed in different nephron segments. SLC38A2′ s encoded pro-
tein, the proximal tubule sodium-coupled neutral amino acid transporter SNAT2, mediates cellular uptake of 
glutamine and other small neutral amino acids46 and also mediates increased proline influx under conditions of 
amino acid deprivation in renal proximal-tubule-like epithelial cells47. The reduction in SNAT2 and SLC38A2 fol-
lowing exosomal exposure was greater than those, typically described as small48, exerted by any specific miRNA 
on any individual target, and this may reflect the whole-urine source of the material used. In animal cells, mature 
microRNAs can work either by reducing the stability of mRNA or by inhibiting translation, by binding specific 
sites in their 3′ UTRs or truncating translation initiation respectively49,50. Thus the observed results for this ami-
noacid transporter could be because of the multiple miRNA binding sites predicted in the same 3′ UTR, implying 
a multiplicative repressive effect51,52, furthermore, multiple miRNAs of different families are known to act 
synergistically53. Fewer listed miRNAs were identified as potential downregulators of KCNJ1, which functions in 
the distal nephron, although the protein repression we observed was similar. Unlike SLC38A2, decreased KCNJ1 
gene expression levels following exosomal exposure recovered at the latest time point. These results suggest that 
while for SLC38A2, the major component of the repression is mRNA destabilization, ROMK1 was more transla-
tionally repressed, and perhaps the rebound in transcript levels represents an attempt by the cell to compensate 
for this reduction in protein levels. Others have reported activation of unknown feedback mechanisms for the 
recovery of gene expression54,55, which may account for the different directions of protein and mRNA levels.
Our DAVID analysis also showed where the miRNAs identified might exert regulatory functions; future stud-
ies will be required to perturb the steady state to address this further. Intriguingly, some of the signalling pathways 
enriched have been associated with chronic kidney disease (CKD) and the progression of glomerulosclerosis and 
tubulointerstitial and vascular fibrosis, particularly via transforming growth factor β -independent profibrotic 
pathways56. Also, ‘zinc finger hormone nuclear receptor’ was a GO term enriched in the analysis; specific nuclear 
binding sites for aldosterone, glucocorticoids and vitamin D are localized in the distal part of the nephron and can 
modulate carbohydrate and lipid metabolism, and regulate immune and inflammatory responses57. They are also 
known to be involved in the progression of fibrosis and are already being exploited as pharmacological targets in 
several metabolic diseases58. Finally, exosomes have recently been implicated in the development of metastasis59, 
and transcriptional regulation in cancer too was represented in the KEGG analysis.
Hence, on the basis of our data, we suggest that the presence of significant numbers of miRNAs in urinary 
exosomes might be indicative of potential regulatory roles these small RNAs might play in the kidney, as sup-
ported by both bioinformatic and renal epithelial cell studies. Further studies will be required to assess the impact 
of exosomal miRNAs on pathways that contain potential targets, as well to investigate urinary exosome miRNA 
profiling as a means for the identification of specific biomarkers of disease states.
Methods
Exosomal Isolation and confirmation. Under Cambridgeshire Research Ethics Committee approval 
(08-H0306-62) and with the informed consent of participants, exosomes were isolated from the second void 
urine of healthy volunteers as previously described19. All methods were performed in accordance with the rele-
vant laboratory guidelines and institutional regulations. Briefly, samples were collected in sterilized bottles con-
taining Complete EDTA-free protease inhibitor cocktail tablets, according to the manufacturer’s instructions. 
Immediately after collection, urine samples were centrifuged for 20 min at 17,000 × g at 4 oC using a JA-17 fixed 
angle rotor in a Beckman AVANTI centrifuge. Supernatant was passed through a 0.22 μ m filter membrane and 
ultracentrifuged for 120 minutes at 235,000 × g at 4 oC in a Ti45 fixed-angle rotor, using a Beckman Optim ultra-
centrifuge. Exosomal pellets from individual samples were suspended in 100 μ L of PBS while the final volume of 
pooled samples did not exceed 350 μ L.
Pooled samples used for cell exposure and live cell imaging studies were washed 3 times, re-suspended in 
PBS and used immediately or stored at 4 oC overnight, preserving the integrity of the isolated nanovesicles. 
Protein contents of exosomal samples and exosome-depleted urine were quantified, and the presence of CD63 
and TSG101 as exosomal markers was confirmed by western blotting. To size the isolated nanovesicles, negative 
staining transmission EM was performed according to standard methods.
Exosomal RNA Isolation. RNA extraction for individual and pooled samples of urinary exosomes was per-
formed using miRNeasy Mini Kit with RNeasy MinElute Cleanup Kit according to manufacturer’s instructions. 
RNAs were eluted in 14 μ l of RNAse-free water and miRNA concentrations were measured using the Agilent 
Bioanalyzer 2100 with a small RNA Chip.
Small RNA library preparation and sequencing. The Illumina TruSeq Small RNA-seq Sample 
Preparation Kit was used according to manufacturer’s instructions. The template was total kidney RNA (as pos-
itive control) or the small RNA-enriched fraction purified from exosomes isolated as above from 6 different 
volunteers (3 male, 3 female); libraries were prepared with a unique index before pooling. Amplified libraries 
were resolved on a 6% Novex TBE PAGE gel. DNA fragments of 145 bp to 160 bp were eluted and concentrated 
by ethanol precipitation. Libraries were qPCR-quantified using a KAPA library quantification kit. Samples were 
diluted to 8 pM and sequenced on a MiSeq as 36 bp single end reads.
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Sequencing data analysis. Following adapter removal, the sequencing datasets were pre-processed using 
the FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/). Reads with at least 80% of bases at quality score 
> 30 were kept for further processing, and no length threshold was set for the remaining reads. Stringent bowtie 
parameters were set to increase the accuracy and specificity of mapping including zero mismatches, and only a 
single genomic location was allowed per read. Reads mapped to the E. coli genome (MG1655 for E. coli K-12) 
were discarded. Alignments were done by Bowtie v1.0.160. MicroRNAs and miRNA precursor annotations were 
downloaded from miRBase v19. The remaining reads were mapped to the human genome GRCh37/hg19. The 
annotation of hg19 was downloaded from the ENSEMBL database.
miRNA target prediction and gene enrichment analysis. Predicted miRNA targets were downloaded 
from 5 tools/databases: miRBase, miRanda, PicTar, PITA and miRDB28–32. Co-expression scores were calculated 
as indicated in Gennarino et al.61 to indicate ranked likelihood of being a true target. Gene targets were ana-
lysed through enrichment analysis using the DAVID33 web service and the RDAVIDWebService62 BioConductor 
package in R. Targets were submitted in the form of their main protein product (UniProt Identifiers). Statistical 
evidence of enrichment was assessed by a modified Fisher’s Exact Test within DAVID with false discovery rate of 
0.05 and Benjamini-Hochberg correction for multiple testing.
PCR Amplification of cDNAs. cDNA was prepared by standard methods and PCR-amplified using 
gene-specific primers for SLC38A2 and KCNJ1. Primer sequences are listed in Supplementary Table S6. To com-
pare abundance of exemplar miRNAs, qRT-PCR analysis was performed using individual TaqMan miRNA Assays 
(Supplementary Table S7) according to manufacturer’s instructions. Expression levels were calculated as logarith-
mic values of 2−ΔCt normalized to the small-nucleolar RNA (snoRNA) RNU6B. To evaluate gene expression of 
selected miRNA targets, total RNA was extracted from cultured HKC-8 or HCD cells using the miRNeasy mini 
kit, reverse transcribed using the SuperScript® VILO cDNA Synthesis Kit and subjected to qRT-PCR using the 
SensiFAST™ SYBR® Hi-ROX Kit. Gene expression levels were calculated using the Δ Δ Ct method.
Cell culture and exposure. HKC-8 cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM)/
Nutrient F-12 Ham with 100 Units/ml of penicillin and 100 μ g/ml of Streptomycin at 37 °C and 5% CO2. HCD 
cells were cultured as previously described63. 106 cells were plated in 12-well cell culture plates and fed with 
FBS-free media to avoid other exosome sources. 10 μ g of exosomal protein from a pool of at least 3 urine sam-
ples were added to 90–100% confluent wells, and lysates of the exposed cells were collected 6, 24 or 48 h later. 
Exposures were repeated using 3 different exosomal pools. Supplementary Table S8 list primary antibodies used 
for immunoblotting of selected targets in cell lysates; species-appropriate IRDye® secondary antibodies were used 
and bands were visualized in an Odyssey Infrared Imaging System. ISS, Version 2.1 was used for densitometry 
analysis.
Live cell imaging of cellular internalization of urinary exosomes. Washed pooled urinary exosomes 
were labelled with PKH67 Green Fluorescent Cell Linker Mini Kit, SIGMA according to manufacturer’s instruc-
tions. Dyed exosomes were washed twice with 1% BSA and ultracentrifuged, suspended in serum-free media, 
and utilised for the experiment on the same day. A parallel sample with no exosomes was labelled under the same 
conditions, and constituted the negative control. 106 HCD cells were seeded in glass bottom culture dishes and 
incubated overnight; 70–80% confluent plates were washed with PBS and a 2 μ g/ml solution of Hoechst 33258 was 
used to identify cell nuclei. Unbound dye was washed with Hank’s buffer and 1 ml of FBS free media was added 
to the cell culture plate. PKH67-labelled exosomes or PKH67 only (negative control) were added to Hoechst 
labelled HCD cells and images were recorded every 5 seconds in a Zeiss LSM780 Confocal Microscope at 37 oC 
for approximately 2 h.
Statistical analysis. Data were analysed with GraphPad Prism V5.01 and presented as mean ± SE. 
Differences at 48 h were compared using unpaired Student’s t-test.
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